(Q53264975)

English

Stem cell transcription factor NANOG controls cell migration and invasion via dysregulation of E-cadherin and FoxJ1 and contributes to adverse clinical outcome in ovarian cancers.

scientific article published on 3 September 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/22945654

Stem cell transcription factor NANOG controls cell migration and invasion via dysregulation of E-cadherin and FoxJ1 and contributes to adverse clinical outcome in ovarian cancers. (English)

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/22945654

1 reference

based on heuristic

inferred from title

author name string

M K Y Siu

1

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/22945654

E S Y Wong

2

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/22945654

D S H Kong

3

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/22945654

H Y Chan

4

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/22945654

L Jiang

5

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/22945654

O G W Wong

6

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/22945654

E W-F Lam

7

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/22945654

K K L Chan

8

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/22945654

H Y S Ngan

9

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/22945654

X-F Le

10

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/22945654

A N Cheung

11

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/22945654

language of work or name

0 references

publication date

3 September 2012

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/22945654

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/22945654

32

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/22945654

30

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/22945654

3500-3509

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/22945654

https://scigraph.springernature.com/pub.10.1038/onc.2012.363

0 references

Cancer statistics, 2007

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.363

21 January 2018

Ovarian cancer: strategies for overcoming resistance to chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.363

21 January 2018

Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.363

21 January 2018

The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.363

21 January 2018

Nanog: a new recruit to the embryonic stem cell orchestra

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.363

21 January 2018

The paradox of response and survival in cancer therapeutics

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.363

21 January 2018

Cancer stem cell markers in common cancers - therapeutic implications

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.363

21 January 2018

Identification and characterization of ovarian cancer-initiating cells from primary human tumors

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.363

21 January 2018

Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.363

21 January 2018

Hyaluronan-CD44 interaction activates stem cell marker Nanog, Stat-3-mediated MDR1 gene expression, and ankyrin-regulated multidrug efflux in breast and ovarian tumor cells

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.363

21 January 2018

Core transcriptional regulatory circuitry in human embryonic stem cells

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.363

21 January 2018

Early detection and treatment of ovarian cancer: shifting from early stage to minimal volume of disease based on a new model of carcinogenesis

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.363

21 January 2018

Loss of E-cadherin promotes ovarian cancer metastasis via alpha 5-integrin, which is a therapeutic target

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.363

21 January 2018

The emerging roles of forkhead box (Fox) proteins in cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.363

21 January 2018

FOXO3a mediates the cytotoxic effects of cisplatin in colon cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.363

21 January 2018

Ovarian cancer stem-like side-population cells are tumourigenic and chemoresistant

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.363

21 January 2018

Functional evidence that the self-renewal gene NANOG regulates human tumor development

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.363

21 January 2018

Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.363

21 January 2018

Identification and expansion of human osteosarcoma-cancer-stem cells by long-term 3-aminobenzamide treatment.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.363

21 January 2018

Pathology of ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.363

21 January 2018

Overexpression of NANOG in gestational trophoblastic diseases: effect on apoptosis, cell invasion, and clinical outcome

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.363

21 January 2018

Simultaneous expression of caveolin-1 and E-cadherin in ovarian carcinoma cells stabilizes adherens junctions through inhibition of src-related kinases

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.363

21 January 2018

Expression of cadherins in benign, borderline, and malignant ovarian epithelial tumors: a clinicopathologic study of 60 cases.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.363

21 January 2018

Modulation of Th1 activation and inflammation by the NF-kappaB repressor Foxj1

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.363

21 January 2018

Comparative epigenomics of human and mouse mammary tumors.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.363

21 January 2018

Differential expression and phosphorylation of Pak1 and Pak2 in ovarian cancer: effects on prognosis and cell invasion.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.363

21 January 2018

p21-activated kinase 4 regulates ovarian cancer cell proliferation, migration, and invasion and contributes to poor prognosis in patients

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.363

21 January 2018

Sustained activation of JNK/p38 MAPK pathways in response to cisplatin leads to Fas ligand induction and cell death in ovarian carcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.363

21 January 2018

Modulation ofcis-diamminedichloroplatinum(II) accumulation and sensitivity by forskolin and 3-isobutyl-1-methylxanthine in sensitive and resistant human ovarian carcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.363

21 January 2018

Overexpression of proto-oncogene FBI-1 activates membrane type 1-matrix metalloproteinase in association with adverse outcome in ovarian cancers

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.363

21 January 2018

Characterization of four novel epithelial ovarian cancer cell lines.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.363

31 March 2020

Low expression of Foxo3a is associated with poor prognosis in ovarian cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.363

31 March 2020

Differential expression of the cell-cell adhesion molecule E-cadherin in ascites and solid human ovarian tumor cells

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.363

31 March 2020

Identifiers

10.1038/ONC.2012.363

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/22945654

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/22945654

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53264975&oldid=1366934684"